- Home
- DSY vs BRNS Comparison
DSY vs BRNS Comparison
Compare DSY & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSY
- BRNS
- Stock Information
- Founded
- DSY 2020
- BRNS 2016
- Country
- DSY China
- BRNS United Kingdom
- Employees
- DSY N/A
- BRNS N/A
- Industry
- DSY
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- DSY
- BRNS Health Care
- Exchange
- DSY Nasdaq
- BRNS Nasdaq
- Market Cap
- DSY 57.6M
- BRNS 48.3M
- IPO Year
- DSY N/A
- BRNS 2021
- Fundamental
- Price
- DSY $1.40
- BRNS $1.07
- Analyst Decision
- DSY
- BRNS Strong Buy
- Analyst Count
- DSY 0
- BRNS 1
- Target Price
- DSY N/A
- BRNS $3.00
- AVG Volume (30 Days)
- DSY 4.0M
- BRNS 42.9K
- Earning Date
- DSY 01-01-0001
- BRNS 11-05-2025
- Dividend Yield
- DSY N/A
- BRNS N/A
- EPS Growth
- DSY 120.37
- BRNS N/A
- EPS
- DSY 0.01
- BRNS N/A
- Revenue
- DSY $7,323,356.00
- BRNS $14,969,000.00
- Revenue This Year
- DSY N/A
- BRNS N/A
- Revenue Next Year
- DSY N/A
- BRNS N/A
- P/E Ratio
- DSY $125.80
- BRNS N/A
- Revenue Growth
- DSY 16.37
- BRNS 1766.46
- 52 Week Low
- DSY $0.95
- BRNS $0.64
- 52 Week High
- DSY $7.33
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- DSY 50.74
- BRNS 41.80
- Support Level
- DSY $1.51
- BRNS $1.08
- Resistance Level
- DSY $7.33
- BRNS $1.20
- Average True Range (ATR)
- DSY 0.50
- BRNS 0.10
- MACD
- DSY 0.03
- BRNS -0.01
- Stochastic Oscillator
- DSY 6.61
- BRNS 22.16
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.